Average order value
Median account AOV · USD
Madgicx Research & Labs
Median account AOV: $196.03 USD.
Median account AOV · USD
Enter your average order value to see where it sits.
Within Medical Equipment & Supplies
US Medicare may cover a 12-week CPAP trial for a qualifying obstructive-sleep-apnea diagnosis. Continued coverage requires the provider's face-to-face evaluation and documentation that Medicare's conditions are met and therapy is helping. Keep enquiry, eligibility verification and continued coverage distinct; the form submission itself establishes none of those clinical requirements.
Medicare's US CPAP page describes a 13-month continuous rental period before ownership. It also specifies 20% of the approved amount after the Part B deductible when assignment is accepted. State that program route explicitly; it is not a universal purchase or pricing rule for CPAP sellers.
Under US Medicare's oxygen policy, monthly rental covers the equipment plus necessary supplies, accessories, maintenance and, for gaseous or liquid oxygen, tank or cylinder refills. A hardware-only comparison misses that service scope. Identify what the advertised arrangement includes rather than deriving a device price from account AOV.
Medicare's US oxygen page describes 36 months of equipment rental payments, followed by continued supplier provision of oxygen and equipment for as long as needed, up to five years from the start. Keep those periods separate in offer copy; a payment milestone does not by itself mean service ends.
The median account AOV for Therapeutic Medical Devices is $196.03 USD. This is the middle account-level average order value in the benchmark.
USD · Equal-weight account aggregate. Snapshot read 11 October 2026; underlying reporting period not supplied.
The middle 50% of account AOVs runs from $80.80 to $428.39 USD. This is the interquartile range, not the minimum and maximum.
USD · Equal-weight account aggregate. Snapshot read 11 October 2026; underlying reporting period not supplied.
The 25th-percentile account AOV is $80.80 USD. It marks the lower edge of the middle 50% of this distribution.
USD · Equal-weight account aggregate. Snapshot read 11 October 2026; underlying reporting period not supplied.
The 75th-percentile account AOV is $428.39 USD. It marks the upper edge of the middle 50%, not a performance target.
USD · Equal-weight account aggregate. Snapshot read 11 October 2026; underlying reporting period not supplied.
Each account value is purchase ROAS multiplied by cost per purchase in USD. The benchmark reports the median and middle 50% of those account values. Accounts are counted once and receive equal weight.
USD · Equal-weight account aggregate. Snapshot read 11 October 2026; underlying reporting period not supplied.
No. It is the median of account-level average order values. Each account receives equal weight; it is not a pooled average of every order.
USD · Equal-weight account aggregate. Snapshot read 11 October 2026; underlying reporting period not supplied.
The snapshot was read on 11 October 2026. The underlying reporting period was not supplied. The October 2026 label identifies the page edition, not the period in which the advertising results were measured.
USD · Equal-weight account aggregate. Snapshot read 11 October 2026; underlying reporting period not supplied.
This benchmark covers exact Therapeutic Medical Devices classifications under Medical Equipment & Supplies. It excludes the parent industry and sibling subcategories.
USD · Equal-weight account aggregate. Snapshot read 11 October 2026; underlying reporting period not supplied.
Enter your AOV in USD in the comparison field above. It shows the difference from the median and whether your value falls below, within or above the middle 50%. Your entered amount stays on this page.
USD · Equal-weight account aggregate. Snapshot read 11 October 2026; underlying reporting period not supplied.
The comparison describes position in the account AOV distribution, not profitability. It is not a performance score.
USD · Equal-weight account aggregate. Snapshot read 11 October 2026; underlying reporting period not supplied.
The exports section provides this edition in Markdown and JSON, along with a research index. This private draft is not licensed for public redistribution.
When reuse is permitted, credit Madgicx Research & Labs and link to the exact source. Keep its snapshot date and scope. This private draft is not licensed for public redistribution.
Behind the numbers
Benchmark snapshot read 11 October 2026.
Equal-weight account aggregate · Reporting period not supplied
Median and middle 50% of account-level average order values. Each account value is purchase ROAS multiplied by cost per purchase in USD. Successful classifications, including manual corrections, with positive finite spend, purchases, ROAS and cost per purchase. Accounts are counted once with equal weight. Quartiles use linear interpolation. Root cohorts include direct root classifications and their child categories; exact-child cohorts exclude parent and sibling categories. The source selects the highest-spend coverage row per account among snapshots dated within the preceding 30 days; the underlying reporting period is not supplied. This is a dated aggregate advertising-data snapshot, not business-wide AOV or a census. Comparison colors describe position in the account AOV distribution, not profitability. Your entered amount stays on this page.
Individually authored category research. The brand directory is deferred for this private draft. Taxonomy membership does not establish benchmark coverage.
When reuse is permitted, credit Madgicx Research & Labs and link to the exact source. Keep its snapshot date and scope. This private draft is not licensed for public redistribution.